Transarterial chemoembolisation in patients with hepatocellular carcinoma: low-dose doxorubicin reduces post-embolisation syndrome without affecting survival-prospective interventional study.

Bessar, Ahmed A; Farag, Ahmed; Abdel Monem, Sameh M; Wadea, Fady M; Shaker, Shady E; Ebada, Mahmoud Ahmed; Bessar, Manar A

Bessar, Ahmed A; Farag, Ahmed; Abdel Monem, Sameh M; Wadea, Fady M; Shaker, Shady E; Ebada, Mahmoud Ahmed; Bessar, Manar A.

Afiliação

Bessar AA; Department of Radiodiagnosis, Zagazig University School of Human Medicine, Zagazig, Egypt. ahmedawadbessar@gmail.com.
Farag A; Department of Surgery, Zagazig University School of Human Medicine, Zagazig, Egypt.
Abdel Monem SM; Department of Tropical Medicine, Zagazig University School of Human Medicine, Zagazig, Egypt.
Wadea FM; Department of Internal Medicine, Zagazig University School of Human Medicine, Zagazig, Egypt.
Shaker SE; Department of Internal Medicine, Zagazig University School of Human Medicine, Zagazig, Egypt.
Ebada MA; Department of Radiodiagnosis, National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt.
Bessar MA; Department of Radiodiagnosis, Zagazig University School of Human Medicine, Zagazig, Egypt.

Eur Radiol Exp ; 5(1): 10, 2021 03 02.

Article em En | MEDLINE | ID: mdl-33649930

Assuntos

Carcinoma Hepatocelular; Quimioembolização Terapêutica; Neoplasias Hepáticas; Carcinoma Hepatocelular/tratamento farmacológico; Doxorrubicina/uso terapêutico; Feminino; Humanos; Neoplasias Hepáticas/tratamento farmacológico; Masculino; Estudos Prospectivos

Palavras-chave

Carcinoma (hepatocellular); Chemoembolization (therapeutic); Doxorubicin; Hepatitis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quimioembolização Terapêutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google